Skip to main content

UNITED WE CURE.

We’re Changing How Science Is Done Because Kids Can’t Wait

CBTN doesn’t wait for change—we drive it, turning global collaboration into faster discovery and better futures for children.

RESEARCH COMMUNITYFAMILIES & FOUNDATIONS

UNITED WE CURE.

We’re Changing How Science Is Done Because Kids Can’t Wait

CBTN doesn’t wait for change—we drive it. Through a global network of scientists, clinicians, and advocates, we accelerate discovery, dismantle barriers, and deliver better outcomes, because every child deserves a future filled with possibility.

RESEARCH COMMUNITYFAMILIES & FOUNDATIONS

MAKING THE IMPOSSIBLE POSSIBLE

Powered by the world’s most extensive collection of pediatric brain tumor biosamples, medical data, imaging, and preclinical models, CBTN breaks down research barriers and fuels global collaboration. With research hospitals contributing from every corner of the world and passionate family foundations standing behind our mission, we accelerate the discoveries that will change everything for children.

Building the Data Foundation for Better Treatment Decisions

Building the Data Foundation for Better Treatment Decisions

One of Dr. Sarah Leary’s patients was treated for medulloblastoma, an aggressive, cancerous brain tumor, when he was 3 years old. Years later, he reached a milestone that says a great deal about the life he built after treatment: admission to a competitive university engineering program. Yet that kind of…
Read More
How Tumoroids Advance Pediatric Brain Tumor Research

How Tumoroids Advance Pediatric Brain Tumor Research

At 21, Sidney Ritchie was used to helping other people through surgery. As a surgical technologist at University of Michigan Health, she had spent some time working in operating rooms. Then, in May 2024, an MRI for tingling and numbness ended with a call telling her to go straight to…
Read More
CBTN Collaboration Reveals Potential Treatment Targets for High-Grade Glioma

CBTN Collaboration Reveals Potential Treatment Targets for High-Grade Glioma

Tumor samples collected through the Children’s Brain Tumor Network (CBTN) helped power a collaborative study identifying potential treatment targets and markers associated with outcomes in children, adolescents, and young adults with high-grade glioma. Published in Cell Reports Medicine, the Mount Sinai-led study brought together CBTN, the National Cancer Institute’s Clinical…
Read More